Inaccurate patient selection criteria may be disqualifying one-quarter of patients with chronic sacroiliac joint pain from receiving radiofrequency ablation treatment, according to a Medscape report.
The new study, presented at the American Academy of Pain Medicine's annual meeting, shows that patients' response to intraarticular sacroiliac steroid injections was not an accurate predictor of their subsequent responses to radiofrequency ablation treatment.
Patients with less than 50 perfect pain relief following the injections should not be disqualified from receiving radiofrequency ablation treatment, the study concluded.
The new study, presented at the American Academy of Pain Medicine's annual meeting, shows that patients' response to intraarticular sacroiliac steroid injections was not an accurate predictor of their subsequent responses to radiofrequency ablation treatment.
Patients with less than 50 perfect pain relief following the injections should not be disqualified from receiving radiofrequency ablation treatment, the study concluded.
Related Articles on Pain Management:
Long Term Opioid Use Can Lead to Hormonal Abnormalities, Study Says
Chronic Pain Can be Measured With Bar Code, Researchers Say
Low Dose of Naltexone Reduces Pain in Fibromyalia Patients, Study Finds